BIO is expected to report earnings to rise 37.81% to $2.77 per share on February 13
Q4'24
Est.
$2.77
Q3'24
Beat
by $0.85
Q2'24
Beat
by $1.10
Q1'24
Beat
by $0.14
Q4'23
Beat
by $0.28
The last earnings report on October 30 showed earnings per share of $2.01, beating the estimate of $1.16. With 286.59K shares outstanding, the current market capitalization sits at 9.79B.